Literature DB >> 26895003

Lack of significant association between type 2 diabetes mellitus with longitudinal change in diurnal salivary cortisol: the multiethnic study of atherosclerosis.

Elias K Spanakis1, Xu Wang2, Brisa N Sánchez3, Ana V Diez Roux2, Belinda L Needham4, Gary S Wand1, Teresa Seeman5, Sherita Hill Golden6,7.   

Abstract

Cross-sectional association has been shown between type 2 diabetes and hypothalamic-pituitary-adrenal (HPA) axis dysregulation; however, the temporality of this association is unknown. Our aim was to determine if type 2 diabetes is associated with longitudinal change in daily cortisol curve features. We hypothesized that the presence of type 2 diabetes may lead to a more blunted and abnormal HPA axis profile over time, suggestive of increased HPA axis dysregulation. This was a longitudinal cohort study, including 580 community-dwelling individuals (mean age 63.7 ± 9.1 years; 52.8 % women) with (n = 90) and without (n = 490) type 2 diabetes who attended two MultiEthnic Study of Atherosclerosis Stress ancillary study exams separated by 6 years. Outcome measures that were collected were wake-up and bedtime cortisol, cortisol awakening response (CAR), total area under the curve (AUC), and early, late, and overall decline slopes. In univariate analyses, wake-up and AUC increased over 6 years more in persons with as compared to those without type 2 diabetes (11 vs. 7 % increase for wake-up and 17 vs. 11 % for AUC). The early decline slope became flatter over time with a greater flattening observed in diabetic compared to non-diabetic individuals (23 vs. 9 % flatter); however, the change was only statistically significant for wake-up cortisol (p-value: 0.03). Over time, while CAR was reduced more, late decline and overall decline became flatter, and bedtime cortisol increased less in those with as compared to those without type 2 diabetes, none of these changes were statistically significant in adjusted models. We did not identify any statistically significant change in cortisol curve features over 6 years by type 2 diabetes status.

Entities:  

Keywords:  Cortisol; Diabetes; Epidemiology; HPA axis; Stress

Mesh:

Substances:

Year:  2016        PMID: 26895003      PMCID: PMC4902713          DOI: 10.1007/s12020-016-0887-8

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  50 in total

1.  Association of subclinical hypercortisolism with type 2 diabetes mellitus: a case-control study in hospitalized patients.

Authors:  Iacopo Chiodini; Massimo Torlontano; Alfredo Scillitani; Maura Arosio; Simonetta Bacci; Sergio Di Lembo; Paolo Epaminonda; Giovanni Augello; Riccardo Enrini; Bruno Ambrosi; Guido Adda; Vincenzo Trischitta
Journal:  Eur J Endocrinol       Date:  2005-12       Impact factor: 6.664

Review 2.  Update on late-night salivary cortisol for the diagnosis of Cushing's syndrome: methodological considerations.

Authors:  Hershel Raff
Journal:  Endocrine       Date:  2013-07-10       Impact factor: 3.633

Review 3.  Assessing salivary cortisol in large-scale, epidemiological research.

Authors:  Emma K Adam; Meena Kumari
Journal:  Psychoneuroendocrinology       Date:  2009-07-31       Impact factor: 4.905

Review 4.  Reliability of hypothalamic-pituitary-adrenal axis assessment methods for use in population-based studies.

Authors:  Sherita Hill Golden; Gary S Wand; Saurabh Malhotra; Ihab Kamel; Karen Horton
Journal:  Eur J Epidemiol       Date:  2011-04-30       Impact factor: 8.082

5.  Dimensions of life stress in psychiatric patients.

Authors:  P A Pilkonis; S D Imber; P Rubinsky
Journal:  J Human Stress       Date:  1985

6.  Daytime trajectories of cortisol: demographic and socioeconomic differences--findings from the National Study of Daily Experiences.

Authors:  Arun S Karlamangla; Esther M Friedman; Teresa E Seeman; Robert S Stawksi; David M Almeida
Journal:  Psychoneuroendocrinology       Date:  2013-07-04       Impact factor: 4.905

7.  Socioeconomic and race/ethnic differences in daily salivary cortisol profiles: the multi-ethnic study of atherosclerosis.

Authors:  Anjum Hajat; Ana Diez-Roux; Tracy G Franklin; Teresa Seeman; Sandi Shrager; Nalini Ranjit; Cecilia Castro; Karol Watson; Brisa Sanchez; Clemens Kirschbaum
Journal:  Psychoneuroendocrinology       Date:  2010-01-29       Impact factor: 4.905

Review 8.  Low cortisol and a flattening of expected daytime rhythm: potential indices of risk in human development.

Authors:  M R Gunnar; D M Vazquez
Journal:  Dev Psychopathol       Date:  2001

9.  Flattened circadian cortisol rhythm in type 2 diabetes.

Authors:  F Lederbogen; J Hummel; C Fademrecht; B Krumm; C Kühner; M Deuschle; K-H Ladwig; C Meisinger; H-E Wichmann; H Lutz; B Breivogel
Journal:  Exp Clin Endocrinol Diabetes       Date:  2011-04-06       Impact factor: 2.949

10.  Differences in cortisol awakening response on work days and weekends in women and men from the Whitehall II cohort.

Authors:  Sabine R Kunz-Ebrecht; Clemens Kirschbaum; Michael Marmot; Andrew Steptoe
Journal:  Psychoneuroendocrinology       Date:  2004-05       Impact factor: 4.905

View more
  11 in total

1.  The association of morning serum cortisol with glucose metabolism and diabetes: The Jackson Heart Study.

Authors:  Robin Ortiz; Bjoern Kluwe; James B Odei; Justin B Echouffo Tcheugui; Mario Sims; Rita R Kalyani; Alain G Bertoni; Sherita H Golden; Joshua J Joseph
Journal:  Psychoneuroendocrinology       Date:  2018-12-27       Impact factor: 4.905

2.  Is the hypothalamic-pituitary-adrenal axis disrupted in type 2 diabetes mellitus and is this relevant for bone health?

Authors:  Cristina Eller-Vainicher; Alfredo Scillitani; Iacopo Chiodini
Journal:  Endocrine       Date:  2017-01-28       Impact factor: 3.633

3.  Is the hypothalamic-pituitary-adrenal axis disrupted in type 2 diabetes mellitus?

Authors:  Hershel Raff; Steven B Magill
Journal:  Endocrine       Date:  2016-09-30       Impact factor: 3.633

4.  IN MY OWN WORDS: THE VALUE OF STORYTELLING TO SHAPE THE ACADEMIC MEDICINE JOURNEY.

Authors:  Sherita Hill Golden
Journal:  Trans Am Clin Climatol Assoc       Date:  2018

Review 5.  Diabetes in Cushing Disease.

Authors:  G Mazziotti; A M Formenti; S Frara; F Maffezzoni; M Doga; A Giustina
Journal:  Curr Diab Rep       Date:  2017-05       Impact factor: 4.810

6.  DNA methylation and sex-specific expression of FKBP5 as correlates of one-month bedtime cortisol levels in healthy individuals.

Authors:  Richard S Lee; Pamela B Mahon; Peter P Zandi; Mary E McCaul; Xiaoju Yang; Utsav Bali; Gary S Wand
Journal:  Psychoneuroendocrinology       Date:  2018-07-04       Impact factor: 4.905

Review 7.  Cortisol dysregulation: the bidirectional link between stress, depression, and type 2 diabetes mellitus.

Authors:  Joshua J Joseph; Sherita H Golden
Journal:  Ann N Y Acad Sci       Date:  2016-10-17       Impact factor: 5.691

8.  The longitudinal association of changes in diurnal cortisol features with fasting glucose: MESA.

Authors:  Jenny Pena Dias; Joshua J Joseph; Bjorn Kluwe; Songzhu Zhao; Michelle Shardell; Teresa Seeman; Belinda L Needham; Gary S Wand; David Kline; Guy Brock; Cecilia Castro-Diehl; Sherita Hill Golden
Journal:  Psychoneuroendocrinology       Date:  2020-07-13       Impact factor: 4.905

Review 9.  The Bidirectional Relationship between Diabetes and Depression: A Literature Review.

Authors:  Abdallah Alzoubi; Rnad Abunaser; Adi Khassawneh; Mahmoud Alfaqih; Aws Khasawneh; Nour Abdo
Journal:  Korean J Fam Med       Date:  2018-05-18

10.  Effects of tofogliflozin on adrenocorticotropic hormone, renin and aldosterone, and cortisol levels in elderly patients with diabetes mellitus: A retrospective study of a patient cohort.

Authors:  Toshihiro Higashikawa; Tomohiko Ito; Takurou Mizuno; Keiichirou Ishigami; Kengo Kuroki; Naoto Maekawa; Daisuke Usuda; Takuro Morita; Kazu Hamada; Susumu Takagi; Kento Takeshima; Shinya Yamada; Ryusho Sangen; Toshihide Izumida; Hideyuki Mori; Jun Kiyosawa; Atsushi Saito; Masaharu Iguchi; Takeshi Nakahashi; Yuji Kasamaki; Akihiro Fukuda; Tsugiyasu Kanda; Masashi Okuro
Journal:  Medicine (Baltimore)       Date:  2021-11-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.